AccuGene strives to become the leader in genomic analysis and molecular diagnostics research.
Researchers at AccuGene are conducting research in various fields in the medical environment such as
new technology development, product safety analysis, product development, etc.

R&D History

2022
2021
2020

Jun

- SMTECH selects AccuGene as a promising company in the market expansion project for the small and mid-sized venture companies
(Title : Development of oral and other disease diagnosis services through oral microbiome analysis)

Feb

- Publication featured in the Food Research International
(Title : Long-term population dynamics of viable microbes in a closed ecosystem of fermented vegetables)

Jan

- Selected as an innovative growth support project for small and medium-sized venture companies in the BIG3 field
(Title : Active oral microbiome analysis service for monitoring digestive/respiratory/skin diseases)

Jul

- Publication featured in the Metabolites
(Title : Gut Microbiome and Metabolome Profiles Associated with High-Fat Diet in Mice)

Jun

- Publication featured in the Metabolites
(Title : Identification of salivary microorganisms and metabolites associated with halitosis)

Apr

- Selected for indoor air biological hazard management technology development project
(Title : Development of health impact assessment system for indoor air biohazard factors)

Feb

- Registered patent for the conversion method of genetic information common data models

Dec

- Selected as a company with excellence in the BIG3 Project
(Excellent evaluation items : Sales Growth and Job Creation)

Nov

- Publication featured in the Molecules journal
(Title : Effect of Fungi on Metabolite Changes in Kimchi During Fermentation)

Oct

- AccuViral Collection Kit FDA EUA Registration

Aug

- Publication featured in the LWT-Food Science and Technology
(Title : Factors affecting vinegar metabolites during two-stage fermentation through metabolomics study)

Jul

- The Korea Institute for the Advancement of Technology(KIAT) selects AccuGene as a company that supports the innovative growth of small and medium venture companies for “Gut Microbiome Analysis Service” in the BIG3 Sectors
- Publication featured in the Journal of Microbiology
(Title : Intervention with kimchi microbial community ameliorates obesity by regulating gut microbiota, 1 co-lead author, 1 co-author)

May

- SMTECH selects AccuGene as a promising company in the market expansion project for the small and mid-sized venture companies
(Title : Development of NGS-based medical device for the diagnosis of hereditary colorectal cancer)

Apr

- AccuViral RNA Preparation Kit Development

Mar

- AccuViral Collection Kit Development